Effect of Carvedilol on Survival in Severe Chronic Heart Failure
ACC Current Journal Review, 2001 · paper · Clinical trials
A double-blind trial of 2,289 patients with severe chronic heart failure randomized to carvedilol or placebo. Carvedilol cut the risk of death by 35% and the combined risk of death or hospitalization by 24%.
0 findings
None that passed a second check.
1 minor (typos and the like; most checked by the judge only)
Typo Reference 11 prints the third author as "Qin F, Shite J, Liand C-S.", which is probably a misspelling of "Liang C-S".
- p. 7 References, ref 11
Qin F, Shite J, Liand C-S.
Only the authors can say what is right here.
Judge's note: Rests on outside knowledge: that the third author of this ferret oxidative-stress abstract is C-S Liang. The page 7 image shows "Liand C-S", and the text layer matches. The investigator appendix lists "C. Liang", which supports reading this as a one-letter substitution. Only the authors or the cited abstract can confirm the correct spelling.
Second check: none (judge only)